called "the largest trial ever of colchicine in acute MI," showed no hint of benefit in an adverse event curve for colchicine relative to placebo over 5 years, which suggests that the role of this ...

The trial was small and halted early, but investigators say the inflammatory hypothesis in TAVI is worth pursuing further.